Dilatation, Pathologic: Clinical Trials

1 trial for Dilatation, Pathologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1
Phase 31Withdrawn 1

Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Corneal Crosslinking in Keratoconus and Corneal Ectasia
Riboflavin, Placebo - Progressive Keratoconus, Corneal Ectasia
Phase 2 / Phase 3WithdrawnOhio State University2008-04-012017-04-20

Narrower conditions

Corneal Diseases (1)  ·  Keratoconus (1)

Broader conditions

Eye Diseases (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Riboflavin (1)

Sponsors

Ohio State University (1)

Countries

United States (1)

Top investigators

Richard Keates, MD (1)